Does TADALAFIL Cause Decreased activity? 86 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Decreased activity have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 0.3% of all adverse event reports for TADALAFIL.
86
Reports of Decreased activity with TADALAFIL
0.3%
of all TADALAFIL reports
0
Deaths
8
Hospitalizations
How Dangerous Is Decreased activity From TADALAFIL?
Of the 86 reports, 8 (9.3%) required hospitalization.
Is Decreased activity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 86 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Decreased activity?
NIRAPARIB (586)
SACUBITRIL\VALSARTAN (570)
RUXOLITINIB (558)
DUPILUMAB (231)
LEVOTHYROXINE (201)
TREPROSTINIL (195)
PREDNISONE (193)
ALBUTEROL (190)
EMTRICITABINE\TENOFOVIR DISOPROXIL (186)
TERIPARATIDE (156)
Which TADALAFIL Alternatives Have Lower Decreased activity Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR